Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Feb;141(2):247-8.
doi: 10.4103/0971-5916.155599.

Herpes zoster complicating bortezomib therapy

Kamal Kant Sahu, Subhash Chander Varma  1
Affiliations
Case Reports

Herpes zoster complicating bortezomib therapy

Kamal Kant Sahu et al. Indian J Med Res. 2015 Feb.
No abstract available

PubMed Disclaimer

Figures

Figs
Figs
A, B. Well defined erythematous, crusted erosions with a few vesicular lesions (indicated by black arrows in (B) in a linear pattern over the right D 9-10 dermatome. Figs C, D. Light microscopy using tzanck smear and stained with Wright-Giemsa stain showing giant cells.
See this image and copyright information in PMC

References

    1. Swaika A, Paulus A, Miller KC, Sher T, Almyroudis NG, Ball D, et al. Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients. J Support Oncol. 2012;10:155–9. - PubMed
    1. Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood. 2008;112:1593–9. - PubMed
    1. Vickrey E, Allen S, Mehta J, Singhal S. Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy. Cancer. 2009;115:229–32. - PubMed
    1. Aoki T, Nishiyama T, Imahashi N, Kitamura K. Efficacy of continuous, daily, oral, ultra-low-dose 200 mg acyclovir to prevent herpes zoster events among bortezomib-treated patients: a report from retrospective study. Jpn J Clin Oncol. 2011;41:876–81. - PubMed

Publication types